Document Details

Document Details

Filing Type

8-K (SEC's EDGAR System)

Company Diffusion Pharmaceuticals Inc. (Charlottesville, VA)
Event Date 1/18/2018
Filing Date 1/19/2018

Abstract: 8-K filed by Diffusion Pharmaceuticals Inc. (DFFN) covering Entry into a Material Definitive Agreement; Other Events; and Financial Statements and Exhibits.
Download

File Section(s)

  1. FORM 8-K
  2. EXHIBIT 1.1
  3. EXHIBIT 4.1
  4. EXHIBIT 99.1

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.